🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to explore the efficacy and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01515410
Treatments Being Tested
To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) exte...
Status
Completed
Location
Xenoscience, Inc. (102)
Start Date
2018-11-06
Trial ID
NCT03670953
Treatments Being Tested
This is a multi-center, randomized, double-blind, double-dummy, active cont...
Status
Active Not Recruiting
Location
Xenoscience
Start Date
2019-09-30
Trial ID
NCT04006210
Treatments Being Tested
This is a phase I PK study in healthy males....
Status
Completed
Location
Nuvisan Pharma Services
Start Date
2017-02-21
Trial ID
NCT03055936
The purpose of this study is to investigate the pharmacokinetics of levodop...
Status
Completed
Location
CRST
Start Date
2014-11
Trial ID
NCT02312232
Treatments Being Tested
The primary objective of this study was to demonstrate the superiority of l...
Status
Completed
Location
Site Reference ID/Investigator# 45719
Start Date
2009-01
Trial ID
NCT00357994
The purpose of this study is to investigate the short-term effects of 3 app...
Status
Completed
Location
James J. Peters Veterans Affairs Medical Center
Start Date
2023-01-20
Trial ID
NCT05708274
Treatments Being Tested
It is an open-label, balanced, randomized, five-treatment, five-period, fiv...
Status
Completed
Location
Lambda Therapeutic Research Ltd.
Start Date
2021-10-29
Trial ID
NCT05128175
Treatments Being Tested
The purpose of the study is to investigate PK of levodopa in plasma after r...
Status
Completed
Location
Clinical Pharmacology Unit, Orion Pharma
Start Date
2017-04-19
Trial ID
NCT03140956
Treatments Being Tested
The study had three distinct parts and is described as follows: Part 1: *...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2011-08
Trial ID
NCT01411137
Treatments Being Tested